Logo
Login

Company Executives

$ Management Team

Board of Directors

From the proxy statement filed Apr 27, 2026
Directors
9
serving now
Independent
7 of 9
stated in the proxy
Average tenure
1.9 years
from year joined
CEO also chairs the board
No
Marc Yoskowitz
Director Age On board Independent Committees Other public boards 2025 pay Source
Paul M. Bisaro
Not stated Not stated Independent
Governance and Compliance Committee · Chair
Pleo Pharma, Zoetis Inc., Myriad Genetics, Inc. $6,017,011
Leslie Donato
Not stated 2025
1 year
 Independent None stated RIS Rx $417,615
Katina Dorton
Not stated 2024
2 years
 Independent None stated Fulcrum Therapeutics, TScan Therapeutics, Sonoma Bio, Prelude Therapeutics $3,815,307
Paul Efron
Not stated 2025
1 year
 Independent
Governance and Compliance Committee
None stated $593,505
Scott Hirsch
Not stated 2025
1 year
 Not independent None stated None stated $5,783,257
Sophia Langlois
Not stated 2025
1 year
 Independent
Audit Committee · Chair
Pason Systems Inc. $435,967
Sigurdur O. Olafsson
CEO
 Not stated 2022
4 years
 Not independent None stated None stated Paid as CEO
Marc Yoskowitz
Board chair
 Not stated Not stated Independent None stated Mereo BioPharma $578,908
Jonathan Zinman
Not stated 2023
3 years
 Independent
Audit Committee
MP Topco Holdings, LLC $4,883,660

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

2 disclosed in the proxy filed Apr 27, 2026
Paul Efron
a member of the Board
$709,972
2025

Sale of 7,692 ordinary shares to Paul Efron in a private placement, at a price equal to the cash he would have received for cancelling his outstanding RSUs at the Merger Effective Time.

Open in proxy
Scott Hirsch
a member of the Board
Amount not stated
2025

Compensation received by Scott Hirsch under his Noncompetition and Consulting Agreement.

Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans